# Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers

> **NCT00565708** · PHASE3 · UNKNOWN · sponsor: **National Cancer Centre, Singapore** · enrollment: 1587 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **OTHER:** placebo
- **DRUG:** Acetylsalicylic acid

## Key facts

- **NCT ID:** NCT00565708
- **Lead sponsor:** National Cancer Centre, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-12
- **Primary completion:** 2024-06
- **Final completion:** 2024-06
- **Target enrollment:** 1587 (ACTUAL)
- **Last updated:** 2024-02-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00565708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00565708, "Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00565708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*